From the frontline pharma stocks - Cipla and Dr Reddy’s Laboratories were up 4% each at Rs 655 and Rs 3,715 respectively, while Divi’s Laboratories, Aurobindo Pharma, Lupin and Sun Pharmaceutical Industries gained 1%-2% each on the National Stock Exchange (NSE).
Marksans Pharma ( 20% at Rs 84.60), Elder Pharmaceuticals (20% at Rs 118), Bliss GVS Pharma (8% at Rs 171), Vivimed Labs (7% at Rs 232), Claris Lifesciences (7% at Rs 249), Novartis (6% at Rs 815) and Dishman Pharmaceuticals (5% at Rs 172) were some small-cap pharma stocks that surged 5%-20% each.
At 1530 hours, the CNX Pharma index was up 1.6% or 199 points at 12,464 compared to a 0.44% rise in the CNX Nifty.
According to a PTI report, the government has taken several measures, including setting up of an inter-departmental committee to look into export-related issues and conducting awareness programmes in emerging markets such as Africa, in an effort to boost pharmaceutical exports.
The pharmaceutical sector has a huge potential in terms of increasing exports and the Commerce Ministry is therefore taking many measures to boost overseas shipments, a ministry official said. The official said an inter-ministerial committee to resolve export-related issues has been set up, the report added. CLICK HERE TO READ FULL REPORT
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)